16-week Efficacy and 2-year Safety, Tolerability and Efficacy of Secukinumab in Participants With Active Psoriatic Arthritis



Status:Completed
Conditions:Arthritis, Psoriasis
Therapuetic Areas:Dermatology / Plastic Surgery, Rheumatology
Healthy:No
Age Range:18 - Any
Updated:10/6/2018
Start Date:May 29, 2015
End Date:December 19, 2017

Use our guide to learn which trials are right for you!

Trial Summary
Trial Overview
Inclusion Criteria

A Phase III, Randomized, Double-blind, Placebo-controlled Multicenter Study of Subcutaneous Secukinumab (150 mg) in Pre-filled Syringe, With or Without Loading Regimen, to Demonstrate Efficacy, Safety and Tolerability up to 2 Years in Patients With Active Psoriatic Arthritis (FUTURE 4)

The purpose of this study was to provide 16-week efficacy, safety and tolerability data
versus placebo to support the use of secukinumab 150 mg by subcutaneous (s.c.)
self-administration with or without a loading regimen and maintenance dosing using pre-filled
syringe (PFS) and to assess efficacy, safety and tolerability up to 2 years in subjects with
active PsA despite current or previous NSAID or DMARD therapy


Inclusion Criteria:

- Diagnosis of Psoriatic Arthritis (PsA) classified by ClASsification criteria for
Psoriatic ARthritis (CASPAR) criteria.

- Rheumatoid factor and anti-cyclic citrullinated peptide (CCP) antibodies negative.

- Diagnosis of active plaque psoriasis or nail changes consistent with psoriasis.

- Inadequate control of symptoms with NSAID.

- Other protocol-defined inclusion criteria do apply.

Exclusion Criteria:

- Chest X-ray or chest magnetic resonance imaging (MRI) with evidence of ongoing
infectious or malignant process.

- Subjects taking high potency opioid analgesics.

- Previous exposure to secukinumab or other biologic drug directly targeting
interleukin-17 (IL-17) or IL-17 receptor.

- Ongoing use of prohibited psoriasis treatments / medications.

- Subjects who have ever received biologic immunomodulating agents except for those
targeting TNFα.

- Previous treatment with any cell-depleting therapies.
We found this trial at
21
sites
Novartis Investigative Site
Seattle, Washington 98103
2007
mi
from 43215
Seattle, WA
Click here to add this to my saved trials
Novartis Investigative Site
Albany, New York 12208
513
mi
from 43215
Albany, NY
Click here to add this to my saved trials
Novartis Investigative Site
Burlington, Vermont 05401
590
mi
from 43215
Burlington, VT
Click here to add this to my saved trials
Novartis Investigational Site
Charleston, South Carolina 29407
525
mi
from 43215
Charleston, SC
Click here to add this to my saved trials
Novartis
Denver, Colorado 80262
1159
mi
from 43215
Denver, CO
Click here to add this to my saved trials
Novartis Investigative Site
Duncansville, Pennsylvania 16635
244
mi
from 43215
Duncansville, PA
Click here to add this to my saved trials
Novartis Investigative Site
Greenville, South Carolina 29605
360
mi
from 43215
Greenville, SC
Click here to add this to my saved trials
Novartis Investigative Site
Kogarah, New South Wales 2217
9463
mi
from 43215
Kogarah,
Click here to add this to my saved trials
Novartis Investigative Site
Lincoln, Nebraska 68506
718
mi
from 43215
Lincoln, NE
Click here to add this to my saved trials
Novartis Investigative Site
Mesa, Arizona 85205
1644
mi
from 43215
Mesa, AZ
Click here to add this to my saved trials
Novartis Investigative Site
Mesquite, Texas 75150
901
mi
from 43215
Mesquite, TX
Click here to add this to my saved trials
Novartis Investigative Site
Oklahoma City, Oklahoma 73104
848
mi
from 43215
Oklahoma City, OK
Click here to add this to my saved trials
Novartis Investigative Site
Oklahoma City, Oklahoma 73104
848
mi
from 43215
Oklahoma City, OK
Click here to add this to my saved trials
Novartis Investigative Site
Palm Harbor, Florida 34684
821
mi
from 43215
Palm Harbor, FL
Click here to add this to my saved trials
Novartis Investigative Site
Peoria, Illinois 61615
352
mi
from 43215
Peoria, IL
Click here to add this to my saved trials
Novartis Investigative Site
Saint Clair Shores, Michigan 48081
175
mi
from 43215
Saint Clair Shores, MI
Click here to add this to my saved trials
Novartis Investigative Site
Saint Louis, Missouri 63128
406
mi
from 43215
Saint Louis, MO
Click here to add this to my saved trials
Novartis Investigative Site
Sarasota, Florida 34239
874
mi
from 43215
Sarasota, FL
Click here to add this to my saved trials
Novartis Investigative Site
Seattle, Washington 98103
2007
mi
from 43215
Seattle, WA
Click here to add this to my saved trials
Novartis Investigative Site
Shreveport, Louisiana 71101
787
mi
from 43215
Shreveport, LA
Click here to add this to my saved trials
Novartis Investigative Site
Upland, California 91786
1940
mi
from 43215
Upland, CA
Click here to add this to my saved trials